Metformin use in renal impairment

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS5249
• Study ID:
  40847
• Official title and acronym:
  Metformin use in renal impairment
• DARWIN EU® study:
  No
• Study countries:
  Denmark

  United Kingdom
• Study description:
  No information provided.
• Study status:
  Finalised

Research institutions and networks

Institutions

Aarhus University & Aarhus University Hospital CLINICAL EPIDEMIOLOGY AND DATA SCIENCE, DEPARTMENT OF CLINICAL MEDICINE

Denmark

Boston Collaborative Drug Surveillance Program Boston, USA

Study timelines

Date when funding contract was signed

Planned:31/07/2013

Actual:31/07/2013

Study start date

Planned:16/12/2013

Actual:16/12/2013

Data analysis start date

Planned:16/12/2013

Actual:16/12/2013

Date of interim report, if expected

Planned:31/03/2014

Actual:30/04/2014

Date of final study report

Planned:30/06/2014

Actual:30/06/2014

Sources of funding

EMA

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable